News

CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...
GSK (GSK) stock in focus as the company secures EU approval for Blenrep combo therapies targeting the blood cancer multiple ...
The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...
A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.
Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...
The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.
British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...
London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion deal. Efimosfermin is a phase III-ready, potential best-in-class investigational ...
Dr. Phil McGraw’s Texas-based media company filed for bankruptcy on Wednesday and simultaneously filed a breach of contract lawsuit against business partner Trinity Broadcasting Group, which ...
Where and when to see 4th of July fireworks celebrations from Macy's to Coney Island in NYC, New York, New Jersey and Connecticut in 2025.
Merit Street Media, the multiplatform network owned by former daytime talk show host Dr. Phil McGraw, has filed for bankruptcy less than two years after its launch.